Hyperleptinemia in chronic renal failure

Hormone and Metabolic Research

Volumn 28, Issue 12, 1996, Pages 724-727

  Iida, M ^a,b   Murakami, T ^a   Yamada, M ^a   Sei, M ^a   Kuwajima, M ^a   Mizuno, A ^a   Noma, Y ^a   Aono, T ^a   Shima, K ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

Author keywords

BMI; chronic renal failure; leptin; RIA

Indexed keywords

CREATININE; LEPTIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DEGRADATION; RADIOIMMUNOASSAY; UREA NITROGEN BLOOD LEVEL;

EID: 0030482360     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979887     Document Type: Article

References (14)

1. Hamilton BS, Paglia D, Kwan AYM, Deitel M: Increased obese mRNA expression in omental fat cells from massively obese humans. Nature Med 1: 953-956 (1995).
2. Lonnquist F, Arner P, Nordfors L, Schalling M: Overexpression of the obese (ob) gene in adipose tissue of human obese subjects. Nature Med 1: 950-953 (1995).
3. Murakami T, Iida M, Shima K: Dexamethasone regulates obese expression in isolated rat adipocytes. Bioch Biophys Res Commun 214: 1260-1267 (1995).
4. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295 (1996).
5. Sinha MK, Ohannesian JP, Heiman ML, Kriauciunes A, Stephens TW, Magosin S, Marco C, Caro JF: Nocturnal rise of leptin in lean, obese, and non-insulin-dependent diabetes mellitus subjects. J Clin Invest 97: 1344-1347 (1996).
6. Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte Jr D: Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans. Nature Med 2: 589-593 (1996).
7. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M: Radioimmunoassay of leptin in human plasma. Clin Chem 42: 942-946 (1996).
8. Haffner SM, Stern MP, Mitten H, Wei M, Gingerich RL: Leptin concentrations in diabeti and nondiabetic Mexican-Americans. Diabees 45: 882-884 (1996).
9. Hassink SG, Sheslow DV, Lancey E, Opentanova I, Considine RV, Caro JF: Serum leptin in children with obesity: Relationship to Gender and Development. Pediatrics 98: 201-203 (1996).
10. Brown RC, Aston JP. Weeks I, Woodhead JS: Circulating intact parathyroid hormone measured by a two-site immunochemiluminometric assay. J Clin Endocrinol Metab 65: 407-417 (1987).
11. Kaplan NM: Endocrine Hypertension In: Textbook of Endocrinology. Wilson JD, Foster DW (eds). W. B. Saunders Co, Philadelphia (1992), 707-731.
12. Rubenstein AH, Mako M, Steiner DF, Brown D, Pullman TM: The renal extraction and excretion of proinculin. J Lab Clin Med 76: 868-869 (1970).
13. Jospan JB, Rubenstein AH: Circulating glucagon: plasma profiles and metabolism in health and disease. Diabetes 26: 887-902 (1977).
14. Shima K, Tanaka A, Sawazaki N, Hamabe J, Ranaka R, Kumahara Y, Yanaihara N: Hypermotilinemiia in chronic renal failure. Horm Metab Res 11: 320-321 (1979).